Literature DB >> 21366828

Epidemiology of canine glaucoma presented to University of Zurich from 1995 to 2009. Part 1: Congenital and primary glaucoma (4 and 123 cases).

Ann Refstrup Strom1, Michael Hässig, Tine M Iburg, Bernhard M Spiess.   

Abstract

OBJECTIVE: To investigate the epidemiology of canine congenital and primary glaucoma in the cases presented to the University of Zurich, Vetsuisse Faculty (UZH) from 1995 to 2009.
METHODS: Information was obtained from the computer database of patients examined by members of the UZH Ophthalmology Service, between January 1995 and August 2009. Congenital and primary glaucoma was diagnosed based on the age of onset, the lack of evidence of any antecedent eye conditions, and/or the presence and severity of iridocorneal angle defects. The data was evaluated for breed, gender and age at presentation.
RESULTS: A total of 5984 dogs presented to the UZH Ophthalmology service between 1995 and 2009. Four dogs of different breed were diagnosed with congenital glaucoma and 123 dogs were diagnosed with primary glaucoma. For the primary glaucomas the overall male to female ratio (M:F) was 1:1.41 and the age of onset ranged from 0.12 to 18.3 years with a mean of 7.3 ± 3.6 years. Data suggested a predisposition for primary glaucoma in the Siberian Husky, Magyar Vizsla and Newfoundland from 2004 to 2009.
CONCLUSION: The report presents the epidemiology of canine congenital and primary glaucomas presented to the UZH from 1995 to 2009. A previous suspicion of predisposition for primary glaucoma in the Newfoundland dog (n = 6) and the Magyar Vizsla breed (n = 8) was confirmed.
© 2011 American College of Veterinary Ophthalmologists.

Entities:  

Mesh:

Year:  2011        PMID: 21366828     DOI: 10.1111/j.1463-5224.2010.00855.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  7 in total

1.  Screening ADAMTS10 in dog populations supports Gly661Arg as the glaucoma-causing variant in beagles.

Authors:  John Kuchtey; Jessica Kunkel; Douglas Esson; John S Sapienza; Daniel A Ward; Caryn E Plummer; Kirk N Gelatt; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-13       Impact factor: 4.799

2.  Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Authors:  Kelly A Leary; Kuan-Ting Lin; Juan P Steibel; Christine D Harman; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2019-12-24       Impact factor: 1.644

3.  Safety and efficacy of topically administered netarsudil-latanoprost fixed dose combination (FDC; Rocklatan™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Authors:  Kelly A Leary; Juan P Steibel; Christine D Harman; Amanda L Anderson; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2021-06-04       Impact factor: 1.644

Review 4.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

5.  Determination of morphological, biometric and biochemical susceptibilities in healthy Eurasier dogs with suspected inherited glaucoma.

Authors:  Thomas Boillot; Serge G Rosolen; Thomas Dulaurent; Frédéric Goulle; Philippe Thomas; Pierre-François Isard; Thierry Azoulay; Stéphanie Lafarge-Beurlet; Mike Woods; Sylvie Lavillegrand; Ivana Ivkovic; Nathalie Neveux; José-Alain Sahel; Serge Picaud; Nicolas Froger
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  A novel missense mutation in ADAMTS10 in Norwegian Elkhound primary glaucoma.

Authors:  Saija J Ahonen; Maria Kaukonen; Forrest D Nussdorfer; Christine D Harman; András M Komáromy; Hannes Lohi
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

7.  High intensity focused ultrasound cyclocoagulation in dogs with primary glaucoma: a preliminary study.

Authors:  Pierre-François Isard; Marielle Mentek; David Clément; Aurélie Béglé; Fabrice Romano; Florent Aptel; Iona Mathieson; Thomas Dulaurent
Journal:  Open Vet J       Date:  2018-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.